🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

UPDATE: If you are fully vaccinated against #COVID19, you can resume activities without wearing a mask or staying 6 feet apart, except where required by federal, state, local, tribal or territorial laws, incl. local business and workplace guidance. More: bit.ly/3btJaFU

We have an open post-doc position for a newly funded project in our lab. If you are interested in studying stress signaling and lipid metabolism in brain tumors let's talk. More details👇👇 partners.taleo.net/careersection/… #MedTwitter #AcademicTwitter MGH Neurology Harvard Medical School @MGH_RI

👑 #1 public university 🐻 5 years in a row! 💙 🎉 💛 #1UCLA ucla.in/3txsPqP

We are looking for a research techI/II to join our group MGH Neurology Harvard Medical School @MGH_RI. If you are interested in brain tumor research feel free to reach out. #MedTwitter #AcademicTwitter More info 👇

Attending SNO? check out work from our group led by the outstanding Katharina Eyme EXTH-23 - Preclinical efficacy of a targeted, brain penetrant inhibitor of fatty acid desaturation in glioblastoma cdmcd.co/q9Wgqg #sno2021 #BTSM

Here is our latest work on #lipidmetabolism in #glioblastoma. Fascinating results on what drives sensitivity and resistance to fatty acid inhibitors in glioblastoma. BADRlab Katharina Eyme biorxiv.org/content/10.110…

We are so thrilled to see our work published in Science Translational Medicine on a new therapeutic strategy that inhibits de novo lipid synthesis to treat glioblastoma. Thanks to BADRlab, Katharina Eyme and co-authors. Also, many thanks to AICF for their support.

A compound that targets de novo lipid synthesis in #GliomaStemCells shrinks #glioblastoma tumors in mice, potentiates DNA-damaging agents, and can penetrate the blood-brain barrier.  Read more: scim.ag/1eG Katharina Eyme BADRlab Alessio Sammarco

It is so exciting to see our work highlighted in Nature Reviews Drug Discovery Drugging a metabolic vulnerability in glioblastoma nature.com/articles/d4157…

#GBM are lethal, molecularly heterogeneous tumors – it was unknown whether this molecular diversity led to distinct phenotypes and metabolic lipidomic vulnerabilities. New, open access Cancer Cell paper: sciencedirect.com/science/articl…

Off to Glasgow for #EANO2024. Excited to present some of our work on lipid metabolism in #braintumors. Also proud of Alessandro Sammarco , who was selected to present his work on breast cancer brain metastasis during the Poster Pitches Session EANO @MGH_RI MGH Neurology

👏Congratulations to our #EANO2024 award winners for Best Poster Presentation: Sophie Bockel (Clinical research), Alicia Buck (Basic research), Alessandro Sammarco (Translational research), Cressida Lorimer (Supportive care & quality of life research)! #NeuroOncology #btsm